TREATMENT OF LARGE BASAL-CELL CARCINOMAS WITH INTRALESIONAL INTERFERON-ALPHA-2a

The Lancet

Volumn 331, Issue 8590, 1988, Pages 878-879

  Grob, J J ^a   Collet, A M ^a   Munoz, M H ^a   Bonerandi, J J ^a  

^a Dermatology Service Hôpital Ste Marguerite ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON;

BASAL CELL CARCINOMA; HUMAN; INTRATUMORAL DRUG ADMINISTRATION; LETTER; NORMAL HUMAN; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

AGED; CARCINOMA, BASAL CELL; FACIAL NEOPLASMS; FEMALE; HUMAN; INJECTIONS, INTRADERMAL; INTERFERON TYPE I; MALE; MIDDLE AGE;

EID: 0023928771     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(88)91620-0     Document Type: Letter

References (5)

1. Treatment of basal cell carcinoma with intralesional interferon
2. Interferon study lacked controls
3. Measurement and figure in dermatology
4. Effect of alpha and beta interferons on cultured keratinocytes
5. Adequate follow up for basal cell carcinoma